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1. Introduction 
A number of previous studies have shown that the 
hydrolysis of acetylcholine by acetylcholinesterase 
(EC 3.1.1.7) from a number of sources is accelerated 
by selected ligands [l-3] . It was suggested by one of 
US that this acceleration occurs at the deacetylation 
step in the reaction sequence [2,4-61, by binding of 
the ligands at an allosteric site [7]. Recently we have 
shown that this site could be selectively blocked by a 
water-soluble carbodiimide, 1-ethyl-3(3-dimethyl- 
aminopropyl) carbodiimide hydrochloride (EDAC) 
[8]. It was possible, however, that the ligands may 
also accelerate the rate of acetylation of acetylcho- 
linesterase by substrates [9] 
In this communication, we have shown that only 
the neuromuscular blocking agents accelerate carbp 
mylation of the esteratic site of the enzyme by a 
neutral carbamate, whereas inorganic ions have no ef-. 
feet and small quaternary ammonium compounds in- 
hibit this reaction. All of the ligands examined inhib- 
ited carbamylation by neostigmine. We have demon- 
strated that the same allosteric site that functions in 
the acceleration of deacetylation of the enzyme also 
functions in acceleration of carbamylation, a reaction 
considered analogous to acetylation [lo]. The influ- 
ence of temperature on the ligand-induced activation 
and inhibition of the carbamylation was studied in 
the hope of gaining further information on the related 
mechanisms occurring at the cholinergic receptor [ 111. 
118 
2. Materials and methods 
2.1. Source of enzyme 
Acetylcholinesterase was a partially purified bovine 
erythrocyte preparation from Sigma. At low ionic 
strength, it had a specific activity of 156 E.cmoles of 
acetylcholine hydrolyzed per hr per mg of protein and 
aKM of 22pM. The EDAC-modified enzyme was pre- 
pared as previously described [8] in a concentration 
of 1 mglml, except that the reaction time was increas- 
ed to 7.5 hr to ensure near maximum modification. 
2.2. Source of chemicals 
o-Nitrophenoldimethylcarbamate (NPDC) was pre- 
pared as previously described [6]. Inorganic ions were 
of analytical reagent grade. Tetramethylammonium 
(TMA) and tetraethylammonium (TEA) iodide 
(Baker), decamethonium bromide (K & K) and 
neostigmine bromide (Sigma) were used as received. 
Gallamine triethiodide was a gift from Poulenc Ltd. 
Acetyl- [ 1 -14C] choline iodide (New England Nuclear) 
had a specific activity of 4.53 Ci/mole. Cation ex- 
change resin CGC 24 1, Na+ form, 200-400 meshwas 
Reagent Grade from Baker. 
2.3. Carbamylation measurements 
Carbamylation was measured essentially by reaction 
of acetylcholinesterase with the carbamate in the jack- 
eted microvessel of the Radiometer TTA 3 1 in the ab- 
sence of added ions at pH 7.4, and 25”C, with removal 
of aliquots for radiometric assay at required time pe- 
riods. Specifically, 3 mg of enzyme preparation in 
3.0 ml of glass distilled water was adjusted to pH 7.4 
in the microvessel. Two 10 ~1 aliquots were removed 
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Fig. 1. Effect of temperature on the apparent carbamylation rate constant. A) Control, o; 0.5 mM TMA, a; 50 mM NaCl, l ; 0.1 
PM decamethonium, 0; 10 PM gallamine, K B) 40 mM MgClz, o; 0.2 mM CaClz, 0; 0.5 mM TEA, A. 
and assayed for control activity as described below. 
At zero time 30 fl of an 8.1 mM solution of o- 
nitrophenoldimethylcarbamate in 5% ethanol or a 
7.5 E.~M solution of neostigmine was added to the re- 
action vessel (final concentrations 8.1 X 1 0e5 M and 
7.5 X lo-* M, respectively). At suitable time intervals 
(20-90 set), 10 fl aliquots were removed and assayed 
for remaining enzyme activity. The time period of 
reaction varied from 4- 10 min. 
2.3.1. Radiometric assay 
The 10 /.d aliquots were added to tubes containing 
0.22 ml of 0.1 M sodium phosphate buffer, pH 7.4 
and a mixture of acetylcholine perchlorate and acetyl- 
[ 1.14C] choline iodide to a final total substrate con- 
centration of 1 mM, containing 19.0 nCi per tube 
After 2 min at room temperature the reaction was 
stopped by the addition of 0.2 ml absolute ethanol. 
Tubes were then assayed for remaining free enzyme 
activity by a modification of the procedure of Berg 
and Maickel [ 121, as previously described [ 131. 
3. Results 
Fig. 1 shows Arrhenius-type plots for the carbamy- 
lation of erythrocyte acetylcholinesterase by NPDC 
for the control reaction and in the presence of 0.05 M 
NaCl, 0.5 mM TMA, 0.1 I.IM decamethonium and 
10 E.~M gallamine (fig. 1A) and 0.04 M MgCI2,0.2 mM 
CaCl, and 0.5 mM TEA (fig. 1B). In all cases, the 
plots have been drawn by regression analysis and cor- 
relation coefficients were found to be better than 
0.99. None of the inorganic ions had any effect on 
the NPDC carbamylation rates at the temperatures 
studied (5-3O’C). The small quaternary ammonium 
compounds, TMA and TEA, inhibit carbamylation 
rates at all temperatures. The neuromuscular blocking 
drugs, decamethonium and gallamine, accelerate carb- 
amylation rates about two-fold. Inorganic ions, TMA 
and TEA, and the neuromuscular drugs inhibited the 
carbamylation of acetylcholinesterase by neostigmine, 
presumably by interfering with the binding of the 
quaternary ammonium head of this inhibitor (table 1). 
Table 1 also shows the effect of the ligands on the 
carbamylation (by NPDC) of the EDAC-modified en- 
zyme. Whereas the inhibition of this reaction by TMA 
and TEA is essentially unaffected, acceleration of the 
119 
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Table 1 Table 2 
Comparison of effects of ligands on carbamylation of acetyl- 
cholinesterase by o-nitrophenoldimethylcarbamate and 
neostigmine. 
Ligand Effect on carbamylation ratea 
(mM) 
NPDC Neostigmine 
Unmodified EDAC- UnmodifiedC 
modifiedb 
_ 
TMA (0.5) 0.64 0.78 0.24 
TEA (0.5) 0.64 0.73 0.21 
CaCl2 (0.2) 1.1 _ 0.52 
w.32 (40) 1.0 _ 0.11 
NaCl(50) 1.1 _ 0.26 
Callamine (0.01) 2.3 1.6 0.27 
Decamethonium 
(0.0001) 1.9 1.3 0.49 
a A value of 1 .O represents no effect, less than 1 .O represents 
degree of inhibition and greater than 1.0 the degree of ac- 
celeration. Results refer to reactions at 20°C. 
b Carbamylation rate of the EDAC-modified enzyme at 20°C 
is 4.2 X 10-3.sec-‘, compared to 7.5 X 10m3. set-’ for the 
control. 
’ The carbamylation rate is 6.2 X 1O-3 .sec-’ . 
Effect of ligands on carbamylation rates and thermodynamic 
parameters for acetylcholinesterase inhibition. 
_ 
Ligand Relative carb- AH’ ‘G+ 
(mM) amylation kcal/mole e.u. 
ratea: 
Control 1.00 12.8 -25.6 
TMA (0.5) 0.64 12.0 -29.3 
TEA (0~5) 0.64 12.4 -28.0 
CaCla (0.2) 1.1 13.8 -22.2 
MgC]a (40) 1.0 13.4 -23.7 
NaCl(50) 1.1 13.6 -23.0 
Gallamine (0.01) 2.3 14.1 -19.9 
Decamethonium 
(0.0001) 1.9 10.6 -31.9 
a As in table 1. Results represent carbamylation by NPDC 
at 20°C. 
reaction of the unmodified enzyme by gallamine and 
decamethonium is greatly diminished after EDAC- 
modification. The small amount of acceleration still 
remaining is,probably due to incomplete modification 
of the enzyme by EDAC even after 7.5 hr of reaction. 
Table 2 shows the thermodynamic parameters AHf 
and aS# for the NPDC carbamylation in the presence 
of the various ligands, determined from the slopes and 
intercepts, respectively, of the Arrhenius-type plots in 
fig. 1A and B, as previously described [ 131. 
4. Discussion 
The present data confirm our previous suggestion 
[2,4,5] that the influence of ligands on substrate hy- 
drolysis is determined by the rate limiting step in the 
hydrolysis sequence of that substrate and the condi- 
tions (such as substrate concentration and ionic 
strength) under which the reaction is investigated. 
Thus inorganic ions (CaCl,, MgC12 and NaCl) which 
accelerate the decarbamylation of acetylcholinesterase 
[6] have no effect on the carbamylation of the enzyme 
by the uncharged carbamate (table 1) but inhibit 
to various degrees the reaction by neostigmine 
(either by direct competition for binding of the qua- 
ternary ammonium head at the catalytic anionic site 
or by anticooperative interaction between anionic 
sites) (table 1). As would be predicted from these data 
on the partial reactions of acetylcholinesterase, inor- 
ganic ions accelerate acetylcholine hydrolysis at high 
substrate concentrations [5,9], where deacetylation is 
considered rate limiting [ 141, but inhibit’acetylcholine 
hydrolysis at low substrate concentrations (where 
deacetylation is not rate limiting [ 151). NaCl also inhi- 
bits hydrolysis of a poor quaternary ammonium sub- 
strate where deacetylation cannot be rate limiting [4], 
presumably by interfering with the binding of the 
quaternary ammonium group to the enzyme. Similarly, 
TEA, which in bovine erythrocyte acetylcholinesterase 
accelerates decarbamylation* (at low ionic strength), 
but inhibits carbamylation by both the neutral and 
positively charged carbamates* (table l), accelerates 
acetylcholine [ 5 ,I 0] and phenylacetate [2] hydroly- 
sis at high substrate concentrations, but inhibits their 
* It seems that TEA does not accelerate ither decarbamyla- 
tion [ 31 or acetylcholine hydrolysis [ 91 in electric eel acetyl- 
cholinesterase, probably reflecting a species difference be- 
tween these enzymes [9]. In addition, TEA has been found 
to accelerate the reaction of electric eel acetylcholinesterase 
by methanesulfonyl f uoride [ 1 l] and dimethylcarbamyl 
fluoride [3,10], an effect that may be related to the presence 
of the small fluoride leaving group of these inhibitors. 
120 
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hydrolysis at low substrate concentrations [2,5]. TEA 
also inhibits the hydrolysis of a poor quaternary am- 
monium substrate at all substrate concentrations [5]. 
The situation may be somewhat more complex with 
the neuromuscular blocking agents. Thus, whereas 
decamethonium inhibits decarbamylation [3] and the 
reaction of the enzyme with neostigmine (table l), it 
accelerates carbamylation by the neutral carbamate. 
Decamethonium is a mixed (competitive and noncom- 
petitve) inhibitor of acetylcholine hydrolysis [7], a 
result which is consistent with its effects on the cor- 
responding partial reactions discussed above. It would 
however be of interest to study the effect of deca 
methonium on neutral substrates at low substrate con- 
centrations in case some acceleration is found. Gal- 
lamine, which is one of the more potent accelerators 
of decarbamylation [3,13] and carbamylation by 
NPDC (table l), but inhibits reaction of the enzyme 
with neostigmine (table l), accelerates acetylcholine 
hydrolysis at high substrate concentrations but inhi- 
bits at low substrate concentrations [7] . 
We have shown in a previous report that EDAC, a 
water soluble carbodiimide, reacts with a carboxyl 
group outside the immediate vicinity of the catalytic 
site and prevents acceleration of acetylcholine hydrol- 
ysis by organic and inorganic ligands [8]. Acceleration 
of the decarbamylation reactions by these ligands is 
also blocked after EDAC-modification (unpublished 
results). This study on the effect of acceleratory 
ligands pn carbamylation by NPDC of the esteratic 
site [ 161 of the EDAC-modified enzyme has indi- 
cated that the same allosteric site which is respon- 
sible for modulating increased reactivity of the es- 
teratic site in ‘deacylation’ reactions (decarbamyla- 
tion and deacetylation) also functions in acceleration 
of carbamylation of the esteratic site, since accelera- 
tion by gallamine and decamethonium is greatly re- 
duced after EDAC-modification (table 1). The molec- 
ular mechanism by which this modulation occurs is 
still unknown at present. 
There is no obvious relationship between the com- 
puted thermodynamic parameters of the carbamyla- 
tion by NPDC in table 2 (AH+ and 4sz) and the ki- 
netic effects of the ligands on this reaction. Thus, nei- 
ther acceleration nor inhibition of the reaction is as- 
sociated with a marked change in either enthalpy or 
entropy of the control reaction, which have the val- 
ues 12.8 kcal/mole and -26 e.u., respectively. These 
values are similar to those previously determined for 
the decarbamylation reaction under similar conditions 
(namely, 13.2 kcal/mole and -34 e.u.) [ 131. However, 
whereas the decarbamylation reaction showed ligand 
sensitive discontinuous Arrhenius plots, which were 
interpreted as indicating the occurrence of different 
temperature and ligand dependent forms of the 
dimethylcarbamylated enzyme [ 131, in the present 
study the Arrhenius type plots in the presence or ab- 
sence of ligands are linear. This suggests that the con- 
formation of acetylcholinesterase in the ‘acylated 
form is a more sensitive probe of ligandinduced con- 
formational changes than is the free enzyme. However, 
the possibility that the NPDC structure stabilize a sin- 
gle conformation of the enzyme cannot be eliminated. 
Main [ 171 has found evidence for the occurrence of 
multiple reversible forms of erythrocyte acetylcholine- 
sterase in studies on the inhibition of the free enzyme, 
although demonstration of this effect was dependent 
on the structure of the irreversible inhibitor used. 
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